DeviceTalks Podcast Network

DeviceTalks Podcast Network

DeviceTalks Podcast Network
Country USA
Language EN
Episodes 466
Latest 13.11.2026

The DeviceTalks Podcast Network is a comprehensive feed for MedTech podcasts, featuring over a dozen shows that cover business strategy, market trends, surgical robotics, orthopedics, structural heart, neurology, and more. Subscribers gain access to episodes from leading medical device companies and startups, with discussions on industry challenges and innovations. The network includes shows like DeviceTalks Weekly, AbbottTalks, Boston Scientific Talks, and others, providing a broad overview of the medical device industry.

Episodes

  • How Zimmer Biomet will use AI and robotics to lighten the load on orthopedic surgeons
    How Zimmer Biomet will use AI and robotics to lighten the load on orthopedic surgeons 13.11.2026 52m
    In this episode of DeviceTalks Weekly, Senior Editor Conor Hale sits down with Jonathan Vigdorchik, MD, the chief science, technology and medical affairs officer at Zimmer Biomet, we talked about the company’s new pitch for “surgeon-guided autonomy” in robotic orthopedic procedures. The company aims to build an ecosystem around its robots, implants and analytics platforms that will allow clinicians to predict risks and outcomes, perform precise surgical plans, and track patients’ progress as they recover — with the goal of reducing the total administrative workload and mental burdens on surgeo...
  • Acting on Evidence and Shaping What Comes Next — Medtronic’s Linnea Burman
    Acting on Evidence and Shaping What Comes Next — Medtronic’s Linnea Burman 06.11.2026 54m
    The evidence doesn’t always point toward the outcome you hoped for. Leadership means acting on it anyway. Leadership means being prepared to act on evidence, even when it points toward a difficult decision. In this episode of the Women in MedTech podcast, Host Kayleen Brown talks with Medtronic’s Linnea Burman, SVP and President of Neurovascular, about her journey from communications and patient storytelling to leading a medtech business. Linnea shares how listening, preparedness, and accountability have shaped her approach to leadership—and why building strong teams and an innovation roadmap...
  • A note from Kayleen, we'll be back next week!
    A note from Kayleen, we'll be back next week! 30.10.2026
    I hope we're still friends. Be back next week, promise!
  • Prana Surgical’s CEO Wants to Bring a Lumpectomy Approach to Lung Surgery
    Prana Surgical’s CEO Wants to Bring a Lumpectomy Approach to Lung Surgery 23.10.2026 1h 2m
    In this episode of DeviceTalks Weekly, Host Kayleen Brown talks with Joanna Nathan, CEO and Co-Founder of Prana Surgical, about why catching lung nodules earlier requires a right-sized approach to surgical intervention. Nathan explains Prana’s goal of bringing a lumpectomy approach to lung surgery and how the company is developing its technology to localize and remove nodules while preserving surrounding healthy lung tissue. She distinguishes its initial focus on supporting tissue diagnosis from its longer-term vision of potentially treating lung cancer. Nathan also shares lessons from Prana’s...
  • After FDA Authorization, J&J’s Robotic Surgery President Looks Ahead to OTTAVA’s Commercial Rollout
    After FDA Authorization, J&J’s Robotic Surgery President Looks Ahead to OTTAVA’s Commercial Rollout 16.10.2026 43m
    In this episode of DeviceTalks Weekly, Host Kayleen Brown welcomes back Rocco De Bernardis, Global President for Soft Tissue Robotic Surgery at Johnson & Johnson, to discuss the company’s OTTAVA™ Robotic Surgical System. De Bernardis explains why OTTAVA’s four robotic arms are integrated into the operating table and how the system’s smaller footprint could give surgical teams more room to work while helping hospitals bring robotic surgery to additional operating rooms. He also shares what Johnson & Johnson learned from OTTAVA’s clinical trial, including how the system performed in different op...
  • Designing for the Whole Picture — Cala Health’s Deanna Harshbarger
    Designing for the Whole Picture — Cala Health’s Deanna Harshbarger 09.10.2026 57m
    Better MedTech requires more than one perspective. In this episode of the DeviceTalks Women in MedTech podcast, Host Kayleen Brown talks with Deanna Harshbarger, CEO of Cala Health, about designing for the whole picture, from patients’ everyday needs to the people, evidence, and business decisions that bring a technology to market. A chemical engineer turned business leader, Harshbarger shares lessons from her career at Johnson & Johnson, Boston Scientific, and Medtronic, including helping build Boston Scientific’s deep brain stimulation franchise and gaining experience with connected devices...
  • How the CST Unit Builds With Purpose — Medtronic’s Melaine DiLuzio
    How the CST Unit Builds With Purpose — Medtronic’s Melaine DiLuzio 02.10.2026 57m
    The strongest MedTech innovation doesn't begin with technology in search of an application. It begins with a problem that matters enough to solve. In this episode of the Women in MedTech podcast, Host Kayleen Brown talks with Melaine DiLuzio, Vice President of U.S. Sales for Enabling Technologies within Medtronic’s Cranial & Spinal Technologies (CST) unit, about purposeful innovation—and the responsibility to connect every technology investment to a meaningful clinical need. Melaine shares how more than two decades in MedTech sales, including her progression from associate sales representative...
  • Preceptis CEO Dave Carey on Hummingbird and Helping Kids Avoid the Trauma of Anesthesia
    Preceptis CEO Dave Carey on Hummingbird and Helping Kids Avoid the Trauma of Anesthesia 25.09.2026 54m
    In this episode of DeviceTalks Weekly, Host Tom Salemi talks with Preceptis Medical CEO Dave Carey about his path from MedTech sales to the corner office. Carey shares lessons from launching disruptive technologies at Boston Scientific, Medtronic, Stryker and Pristine Surgical, including what he looks for when hiring salespeople and what it takes to change established clinical workflows. Carey also explains why his new role at Preceptis is personal. After his daughter experienced emergence delirium following anesthesia for an ear tube procedure, Carey was drawn to Hummingbird, Preceptis’ techn...
  • J&J MedTech's Polyphonic Lead Explains Why Surgical Intelligence Is the Next Big Shift in the OR
    J&J MedTech's Polyphonic Lead Explains Why Surgical Intelligence Is the Next Big Shift in the OR 11.09.2026 52m
    In this episode, MassDevice Editor Chris Newmarker interviews Shan Jegatheeswaran, Global President, Polyphonic, Johnson & Johnson MedTech, about what’s to come after the transformation brought to the operating room by digital surgery and robotics. Jegatheeswaran reports that a new wave of surgical intelligence could take that transformation much further by connecting devices, data, AI and clinicians across the entire perioperative pathway. Jegatheeswaran explains why the biggest challenges may no longer be technological. Interoperability, economic incentives, governance, change management and...
  • Xeltis CEO Schutte on Building a Business Around Tech that Helps the Body Build New Blood Vessels
    Xeltis CEO Schutte on Building a Business Around Tech that Helps the Body Build New Blood Vessels 04.09.2026 1h 6m
    In this episode, Host Tom Salemi sits down with Eliane Schutte, CEO of Xeltis, to discuss a remarkable biomaterial designed to help the body grow its own living blood vessels. Schutte explains how the technology is being used for dialysis patients today and how it could eventually transform coronary bypass surgery, peripheral vascular care and even heart valve replacement. In the FOMO studio, Tom speaks with Katie Grant, VP of MR at Siemens Healthineers North America, about the global helium supply and why the MRI industry is working to reduce its reliance on the increasingly precious gas. The...
  • Knowing What “Good” Looks Like — Astrin Biosciences’ Jaime LaMontagne
    Knowing What “Good” Looks Like — Astrin Biosciences’ Jaime LaMontagne 28.08.2026 47m
    The best leaders do more than set a vision. They know what good looks like—and can help others build toward it. In this episode of the Women in MedTech podcast, Host Kayleen Brown talks with Jaime LaMontagne, Chief Marketing Officer of Astrin Biosciences, about the leadership skills behind effective MedTech marketing. Jaime reflects on her 18 years at Medtronic, where she held a series of marketing and leadership roles across urology, neuromodulation, cardiac rhythm, and perfusion. She shares how that experience—along with her work at Smiths Medical and Exact Sciences—shaped her approach to co...
  • Inner Logic CEO Porras explains how autonomous surgery can save us from looming surgeon shortage
    Inner Logic CEO Porras explains how autonomous surgery can save us from looming surgeon shortage 21.08.2026 1h 1m
    In this podcast episode, Tito Porras, MD, MBA, CEO and co-founder of startup Inner Logic, shares his unusual path to MedTech entrepreneurship with Host Tom Salemi. Dr. Porras was training to become a neurosurgeon at Johns Hopkins when he began questioning the limits of surgeon training. He realized that even better training wouldn't solve the larger problem: there aren't enough surgeons to provide the care patients need. That realization eventually led Porras to entrepreneurship and Inner Logic, which is developing intelligence and simulation infrastructure that can help develop devices with g...
  • Medtronic’s Grubb on Bringing a Structuralist Perspective to a Growing Structural Heart Portfolio
    Medtronic’s Grubb on Bringing a Structuralist Perspective to a Growing Structural Heart Portfolio 14.08.2026 1h 14m
    In this episode of DeviceTalks Weekly, Host Tom Salemi welcomes Kendra Grubb, MD, vice president and chief medical officer of Medtronic’s Structural Heart business. Dr. Grubb fulfilled her childhood ambition of becoming a cardiac surgeon and an interventionalist.In this episode, Dr. Grubb discusses how structural heart has transformed over the past two decades and why she believes the field is approaching another major disruption. She explores the future of transcatheter therapies, the growing role of AI, imaging and robotics, the challenge of treating more patients, and how Medtronic is build...
  • How Mobia Medical’s Stroke Recovery Mission Muscled It Past MedTech’s Public Market Malaise
    How Mobia Medical’s Stroke Recovery Mission Muscled It Past MedTech’s Public Market Malaise 07.08.2026 1h 9m
    In this episode of the DeviceTalks Weekly podcast, Mobia Medical CEO Richard Foust explains how the “magical” qualities of the company's neurotechnology helped steer it toward an IPO. Mobia Medical’s implantable pulse generator promotes motor skill recovery in patients who have suffered a stroke. The company’s early commercial success has generated modest revenue, but Foust tells host Tom Salemi that “not all revenue is the same,” explaining why a large, untapped and growing market won over venture capital investors a few years ago and public investors this spring. MassDevice Editor Chris Newm...
  • Surgical Robotics Recap: Steve Bell on SRS, Karl Storz’s Gaudet and Sovato CEO Brian Miller
    Surgical Robotics Recap: Steve Bell on SRS, Karl Storz’s Gaudet and Sovato CEO Brian Miller 31.07.2026 1h 12m
    In this episode of the DeviceTalks Weekly podcast, we tackle a range of topics related to the surgical robotics industry. In our keynote conversation, Brian Miller, formerly of Intuitive and now CEO of Sovato, discusses the potential of telesurgery, a promising capability of surgical robotic systems that could save lives while reducing costs and improving efficiency across the healthcare system. In our FOMO interview, Christy Gaudet, global head of solutions at Karl Storz, explains the company's decision to discontinue the Asensus Surgical robotics systems and focus on the often under-apprecia...
  • Is Fractyl poised to create a new MedTech market by helping former GLP-1 users keep weight off?
    Is Fractyl poised to create a new MedTech market by helping former GLP-1 users keep weight off? 24.07.2026 40m
    In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi is joined by Harith Rajagopalan, MD, PhD, co-founder and CEO of Fractyl Health. Dr. Rajagopalan explains why Fractyl shifted its focus from treating type 2 diabetes to helping former GLP-1 users maintain their weight loss with Revita, an outpatient endoscopic procedure designed to target the root causes of metabolic disease in the duodenum. He also shares new clinical data, the strategy behind Fractyl's pivotal trial, the company's commercialization plans, and why he believes metabolic endoscopy could become an entirely new cat...
  • J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients
    J&J MedTech’s Devi Govender wants to change the lives – and the language – of heart recovery patients 17.07.2026 1h 17m
    In this episode of the DeviceTalks Weekly Podcast, Managing Editor Kayleen Brown sits down with Johnson & Johnson MedTech Heart Recovery Worldwide President Devi Govender at DeviceTalks Boston. Govender shares how a deeply personal family experience shaped her mission to transform cardiovascular care. She reflects on Abiomed's integration into Johnson & Johnson, the evolution of heart recovery therapies, and why the industry must shift its mindset from treating "heart failure" to enabling "heart recovery." The discussion explores patient-centered innovation, AI, clinical evidence, and the powe...
  • XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution
    XCATH’s Eduardo Fonseca on Building a Mission Driven Culture Behind a Robotic Stroke Revolution 10.07.2026 1h 10m
    In this episode of DeviceTalks Weekly, Host Tom Salemi explores the breakthrough technologies—and the unique culture—driving one of MedTech's most ambitious missions with XCATH CEO Eduardo Fonseca. Fonseca shares the remarkable story behind XCATH's first remote robotic stroke procedure. Fonseca recounts the years of preparation, the high-stakes operation, and the emotional moment when a patient facing severe disability walked away with what he calls "a second birthday." Along the way, Tom and Eduardo discuss AI's growing role in surgery, the global shortage of stroke specialists, the future of...
  • Can Calyxo CEO Catanese Lead New Company Down Familiar Tract to Build Another Urology Powerhouse
    Can Calyxo CEO Catanese Lead New Company Down Familiar Tract to Build Another Urology Powerhouse 26.06.2026 1h 15m
    In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi is reassured by his conversation with Joe Catanese, CEO of Calyxo, a urology startup that has developed a system designed to simplify kidney stone removal. Catanese previously helped build Neotract, a urology startup that was acquired by Teleflex for more than $1 billion. Now, he's leading another potential gamechanger and may have his sights set on an IPO. Speaking of gamechangers, HistoSonics continues to shatter fundraising expectations. The company recently completed a financing round that valued it at $3.75 billion. In thi...
  • Reeve Stoffer Explains Why a Reset Might Have Been the Best Thing for Recor Medical and Renal Denervation
    Reeve Stoffer Explains Why a Reset Might Have Been the Best Thing for Recor Medical and Renal Denervation 19.06.2026 1h 1m
    In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi visits his MedTech happy place — renal denervation — with Recor Medical COO Helen Reeve Stoffer. Reeve Stoffer joined the company shortly before the bottom fell out of the renal denervation market in 2014. This interview picks up from that point and follows Recor's pursuit of FDA approval to where denervation technology may be applied next. This week’s FOMO features a portion of a keynote interview with Manny Villafaña, MedTech legend and CEO of Medical 21. The conversation took place at DeviceTalks Minnesota and focuses on the...

Popular in

The podcast also appears in the podcast charts of these countries.